The abstract submission deadline for the 21st Annual Meeting of the Translational Research Cancer Centers Consortium has been extended to January 20. The WVU Cancer Institute is the organizing center of this year’s meeting titled Out of the Valley: Moving Mountains for the Immunotherapy of Cancer and scheduled for February 14-16, 2018, at Seven Springs Mountain Resort in Seven Springs, PA. Visit www.trccc.org for registration, abstract submission, and additional details.
Keynote presentations will be made by two outstanding researchers: Dr. Robert L. Ferris, director of the UPMC Hillman Cancer Center and Hillman Professor of Oncology at the University of Pittsburgh and Dr. Pamela Ohashi, PhD, FRSC, professor in the department of immunology and medical biophysics at the University of Toronto. She also is director of the Immune Therapy Program at Ontario Cancer Institute.
Cancer Institute Director Rich Goldberg, MD; HSC Senior Associate Vice President for Research & Graduate Education and Cancer Institute Deputy Director Laura Gibson, PhD; and Associate Professor of Chemical and Biomedical Engineering and Cancer Institute researcher David Klinke, PhD, are the chairs of the event, which brings together leaders in immunotherapy and other biologic therapies. Patrick Ma, MD, co-leader of the Cancer Institute’s Allen Lung Cancer Program, will present a talk titled Immunotherapies in lung cancer and Dr. Goldberg will present a talk on the extraordinary results of a clinical trial that saved the life of one of his patients at The Ohio State University Comprehensive Cancer Center.
Lauren F. Gibson, Ph.D., senior associate vice president for research and graduate education at WVU Health Sciences, has been selected as a fellow in the Hedwig van Ameringen Executive Leadership in Academic Medicine Program for Women at Drexel University College of Medicine.
Patrick Ma, M.D., co-leader of the WVU Cancer Institute Sara Crile Allen & James Frederick Allen Comprehensive Lung Cancer Program and director of the Clinical Lung Cancer Program, and Xiaoliang Wu, M.D., Ph.D., postdoctoral research fellow in Dr. Ma’s lab, were featured presenters at the 2018 American Society of Clinical Oncology (ASCO) Annual Scientific Meeting this June.